All stock lists
Carlsmed, Inc. (NASDAQ:CARL)
US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
14.80+0.27 (+1.86%)
Insider Score
––Not scored
CARL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CARL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 18.94 M | 16.12 M | 15.16 M | 13.07 M | 12.08 M | 10.19 M |
| Revenue Growth (YoY) | 56.75 % | 58.17 % | 61.19 % | 98.39 % | 98.70 % | 100.33 % |
| Cost of Revenue | 4.40 M | 3.69 M | 3.56 M | 3.15 M | 3.21 M | 2.55 M |
| Gross Profit | 14.54 M | 12.43 M | 11.61 M | 9.93 M | 8.87 M | 7.64 M |
| SG&A Expense | 19.54 M | 16.52 M | 15.66 M | 14.52 M | 11.21 M | 10.21 M |
| R&D Expense | 6.04 M | 5.18 M | 5.26 M | 4.45 M | 4.16 M | 3.15 M |
| Operating Expenses | 25.58 M | 21.70 M | 20.93 M | 18.96 M | 15.37 M | 13.36 M |
| Operating Income | -11.04 M | -9.28 M | -9.32 M | -9.04 M | -6.50 M | -5.72 M |
| Pretax Income | 0.00 | -8.70 M | -8.61 M | -8.53 M | -6.77 M | -5.73 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -10.51 M | -8.70 M | -8.61 M | -8.53 M | -6.77 M | -5.73 M |
| EPS (Basic) | -0.39 | -0.32 | -0.25 | -0.40 | -1.47 | -0.33 |
| EPS (Diluted) | -0.39 | -0.32 | -0.25 | -0.40 | -1.47 | -0.33 |
| Shares Outstanding | 27.19 M | 26.84 M | 14.22 M | 21.08 M | 4.59 M | 19.17 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.